COULD AUTOPHAGY-RELATED PROTEINS BE A BIOMARKER IN EARLY PARKINSON'S DISEASE? POTENTIAL NOVEL CSF BIOMARKERS IN PARKINSON'S DISEASE

被引：0
|
作者：
Jang, W. [1 ]
Youn, J. [2 ]
机构：
[1] Univ Ulsan, Gangneung Asan Hosp, Neurol, Kangnung, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Neurol, Seoul, South Korea
来源：
PARKINSONISM & RELATED DISORDERS | 2018年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-096
引用
收藏
页码：E65 / E65
页数：1
相关论文
共 50 条
  • [31] Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
    Nour K. Majbour
    Nishant N. Vaikath
    Karin D. van Dijk
    Mustafa T. Ardah
    Shiji Varghese
    Louise B. Vesterager
    Liliana P. Montezinho
    Stephen Poole
    Bared Safieh-Garabedian
    Takahiko Tokuda
    Charlotte E. Teunissen
    Henk W. Berendse
    Wilma D. J. van de Berg
    Omar M. A. El-Agnaf
    Molecular Neurodegeneration, 11
  • [32] Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease
    Majbour, N. K.
    Vaikath, N. N.
    Dijk, K. D.
    Ardah, M.
    Teunissen, C. E.
    Berendse, H. W.
    Berg, W. D. J.
    El-Agnaf, O. M. A.
    MOVEMENT DISORDERS, 2016, 31 : S630 - S630
  • [33] Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
    Chen Tian
    Genliang Liu
    Liyan Gao
    David Soltys
    Catherine Pan
    Tessandra Stewart
    Min Shi
    Zhiying Xie
    Na Liu
    Tao Feng
    Jing Zhang
    Translational Neurodegeneration, 8
  • [34] Erythrocytic α-Synuclein as a potential biomarker for Parkinson's disease
    Tian, Chen
    Liu, Genliang
    Gao, Liyan
    Soltys, David
    Pan, Catherine
    Stewart, Tessandra
    Shi, Min
    Xie, Zhiying
    Liu, Na
    Feng, Tao
    Zhang, Jing
    TRANSLATIONAL NEURODEGENERATION, 2019, 8 (1)
  • [35] Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease
    Michelle E.Fullard
    James F.Morley
    John E.Duda
    Neuroscience Bulletin, 2017, 33 (05) : 515 - 525
  • [36] Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease
    Fullard, Michelle E.
    Morley, James F.
    Duda, John E.
    NEUROSCIENCE BULLETIN, 2017, 33 (05) : 515 - 525
  • [37] Olfactory Dysfunction as an Early Biomarker in Parkinson’s Disease
    Michelle E. Fullard
    James F. Morley
    John E. Duda
    Neuroscience Bulletin, 2017, 33 : 515 - 525
  • [38] Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program
    Gwinn, Katrina
    David, Karen K.
    Swanson-Fischer, Christine
    Albin, Roger
    St Hillaire-Clarke, Coryse
    Sieber, Beth-Anne
    Lungu, Codrin
    Bowman, F. DuBois
    Alcalay, Roy N.
    Babcock, Debra
    Dawson, Ted M.
    Dewey, Richard B., Jr.
    Foroud, Tatiana
    German, Dwight
    Huang, Xuemei
    Petyuk, Vlad
    Potashkin, Judith A.
    Saunders-Pullman, Rachel
    Sutherland, Margaret
    Walt, David R.
    West, Andrew B.
    Zhang, Jing
    Chen-Plotkin, Alice
    Scherzer, Clemens R.
    Vaillancourt, David E.
    Rosenthal, Liana S.
    BIOMARKERS IN MEDICINE, 2017, 11 (06) : 451 - 473
  • [39] Novel biomarkers of Parkinson's disease: CSF concentrations of xanthine, homovanillic acid, and their ratio
    LeWitt, P. A.
    Schultz, L.
    Auinger, P.
    MOVEMENT DISORDERS, 2011, 26 : S193 - S194
  • [40] AUTOPHAGY AND AUTOPHAGY-RELATED PROTEIN EXPRESSION IN THE SUBSTANTIA NIGRA AND DRUG INTERVENTION IN RAT MODELS OF PARKINSON'S DISEASE
    Liu, B.
    Sun, J.
    Zhang, J. X.
    Ma, Y. Y.
    Mao, W. J.
    Li, S. Y.
    Lv, C. N.
    Cheng, X. H.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 117 : 3 - 3
12345